Oxidative stress in sudden infant death syndrome

Journal of Child Neurology

Volumn 11, Issue 6, 1996, Pages 433-438

  Huggle, Stefanie ^a   Hunsaker III, John C ^a   Coyne, Carolyn M ^a   Sparks, D Larry ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; NEWBORN DISEASE; OXIDATIVE STRESS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SUDDEN INFANT DEATH SYNDROME;

EID: 0029798139     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389601100603     Document Type: Article

References (31)

1. Naeye RL: Hypoxia and the sudden infant death syndrome. Science 1974;186:837-838.
2. Kalaria RN, Fiedler C, Hunsaker JC, Sparks DL: Synaptic neurochemistry of human striatum during development: changes in sudden infant death syndrome. J Neurochem 1993;60:2098-2105.
3. Weissbluth L, Weissbluth M: Sudden infant death syndrome: A genetically determined maturation of the photoneuroendocrine system. J Theor Biol 1994;167:13-25.
4. Valdes-Dapena M: The pathologist and the sudden infant death syndrome. Am J Pathol 1982;106:118-131.
5. Risse M, Weiler G: Differential diagnosis SIDS/non-SIDS on the basis of histological findings of petechial thymus hemorrhages. Forensic Sci Int 1989;43:1-7.
6. Campell CJ, Read DJ: Circulatory and respiratory factors in the experimental production of lung petechiae and their possible significance in the sudden infant death syndrome. Pathology 1980; 12:181-188.
7. Bruce K, Becker LE: Quantitation of medullary astrogliosis in sudden infant death syndrome. Pediatr Neurosurg 1992;17:74-79.
8. Yamanouchi H, Takashima S, Becker LE: Correlation of astrogliosis and substance P immunoreactivity in the brainstem of victims of sudden infant death syndrome. Neuropediatrics 1993;24: 200-203.
9. O'Kusky JR, Norman MG: Sudden infant death syndrome: increased synaptic density in the central reticular nucleus of the medulla J Neuropathol Exp Neurol 1994;53:263-271.
10. Sparks DL, Davis DG, Bigelow TM, et al: Increased ALZ-50 immunoreactivity in sudden infant death syndrome. J Child Neurol 1996;11:101-107.
11. Wolozin B, Scicutella A, Davies P: Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1988;85:6202-6206.
12. Hyman BT, Van Hoesen GW, Wolozin BL, et al: Alz-50 antibody recognizes Alzheimer-related neuronal changes. Ann Neurol 1988;23: 371-379.
13. Sparks DL, Landers T, Scheff SW, et al: Apoptotic neurodegeneration in sudden infant death syndrome, abstract. J Neuropathol Exp Neurol 1995;54:415.
14. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 1980;68:251-306.
15. Oppenheim RW: Cell death during development of the nervous system. Annu Rev Neurosci 1991;14:453-501.
16. Cunningham TJ: Naturally occurring neuron death and its regulation by developing neuronal pathways. Int Rev Cytol 1982;74: 163-185.
17. Raff M: Social controls on cell survival and cell death. Nature 1992; 356:397-399.
18. Obeid LM, Linardic CM, Karolak LA, et al: Programmed cell death induced by ceramide. Science 1993;259:1769-1771.
19. Barinaga M: Death gives birth to the nervous system. But how? Science 1993;259:762-763.
20. Richardson JS, Subbarao KV, And LC: On the possible role of iron-induced free radical peroxidation in neural degeneration in Alzheimer's disease. Ann N Y Acad Sci 1992;648:326-327.
21. Kane DK, Sarafian TA, Anton R, et al: Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 1993;262:1274-1277.
22. Sparks DL, Hunsaker JC III: Increased ALZ-50-reactive neurons in the brains of SIDS infants: An indicator of greater neuronal death? J Child Neurol 1991;6:123-127.
23. Willinger M, James LS, Catz C: Defining the sudden infant death syndrome (SIDS): Deliberations of an expert panel convened by the National Institute of Child Health and Human Development. Pediatr Pathol 1991;11:677-684.
24. Aria K, Maguchi S, Fujii S, et al: Glycation and inactivation of human Cu-Zn-superoxide dismutase: Identification of the in vitro glycated sites. J Biol Chem 1987;262:16969-16972.
25. Arai K, Iizuka S, Makita A, et al: Purification of Cu-Zn-superoxide dismutase from human erythrocytes by immunoaffinity chromatography: Evidence for the presence of isoelectric heterogeneity. J Immunol Methods 1986;91:139-143.
26. Furuta A, Price DL, Pardo CA, et al: Localization of superoxide dismutase in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am J Pathol 1995;146:357-366.
27. Shaw C-M, Siebert JR, Haas JE, et al: Megalencephaly in sudden infant death syndrome. J Child Neurol 1989;4:39-42.
28. Aranda FT, Teixeira F, Becker LE: Assessment of growth in sudden infant death syndrome. Neuroepidemiology 1990;9:95-105.
29. Kinney HC, Brody BA, Finkelstein DM, et al: Delayed central nervous system myelination in the sudden infant death syndrome. J Neuropathol Exp Neurol 1991;50:29-48.
30. Brugge KL, Nichols S, Delis D, et al: The role of alterations in free radical metabolism in mediating cognitive impairments in Down's syndrome. Free Radic Aging 1992;62:190-198.
31. Groner Y, Elroy-Stein O, Bernstein Y, et al: Molecular genetics of Down's syndrome: Overexpression of transfected human Cu/Zn-superoxide dismutase gene and the consequent physiological changes. Cold Spring Harb Symp Quant Biol 1986;51(1):381-393.